Cafepharma Today

Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Motley Fool
Tuesday, June 1, 2010 - 6:00pm
Pharmalot
Tuesday, June 1, 2010 - 1:02pm
tags:
In-Pharma Technologist
Tuesday, June 1, 2010 - 9:19am
Fierce Biotech Research
Tuesday, June 1, 2010 - 9:18am
Bloomberg
Tuesday, June 1, 2010 - 9:07am
tags:
Forbes
Tuesday, June 1, 2010 - 9:04am
Seeking Alpha
Tuesday, June 1, 2010 - 9:03am
tags:
Reuters
Tuesday, June 1, 2010 - 6:11am
Yahoo
Tuesday, June 1, 2010 - 6:10am
tags:
Bloomberg
Tuesday, June 1, 2010 - 5:55am
Motley Fool
Tuesday, June 1, 2010 - 5:51am
FT.com
Tuesday, June 1, 2010 - 5:50am
tags:
Seeking Alpha
Tuesday, June 1, 2010 - 5:44am

Pages

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.